Seres Therapeutics Stock Price History

MCRB Stock  USD 0.86  0.05  6.17%   
Below is the normalized historical share price chart for Seres Therapeutics extending back to June 26, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Seres Therapeutics stands at 0.86, as last reported on the 30th of January, with the highest price reaching 0.88 and the lowest price hitting 0.81 during the day.
IPO Date
26th of June 2015
200 Day MA
0.8885
50 Day MA
0.8333
Beta
2.05
 
Yuan Drop
 
Covid
If you're considering investing in Seres Stock, it is important to understand the factors that can impact its price. Seres Therapeutics appears to be extremely dangerous, given 3 months investment horizon. Seres Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.041, which indicates the firm had a 0.041 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Seres Therapeutics, which you can use to evaluate the volatility of the company. Please review Seres Therapeutics' Semi Deviation of 4.21, risk adjusted performance of 0.0466, and Coefficient Of Variation of 2212.51 to confirm if our risk estimates are consistent with your expectations.
  
At present, Seres Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 163 K, whereas Total Stockholder Equity is projected to grow to (38.4 M). . As of January 30, 2025, Price To Sales Ratio is expected to decline to 1.21. In addition to that, Price Earnings Ratio is expected to decline to -1.49. Seres Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.041

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMCRB
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 6.71
  actual daily
59
59% of assets are less volatile

Expected Return

 0.28
  actual daily
5
95% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
3
97% of assets perform better
Based on monthly moving average Seres Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seres Therapeutics by adding it to a well-diversified portfolio.
Price Book
5.7469
Enterprise Value Ebitda
(2.07)
Price Sales
1.0882
Shares Float
98.6 M
Wall Street Target Price
3.874

Seres Therapeutics Stock Price History Chart

There are several ways to analyze Seres Stock price data. The simplest method is using a basic Seres candlestick price chart, which shows Seres Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 29, 20240.98
Lowest PriceNovember 15, 20240.55

Seres Therapeutics January 30, 2025 Stock Price Synopsis

Various analyses of Seres Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Seres Stock. It can be used to describe the percentage change in the price of Seres Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Seres Stock.
Seres Therapeutics Price Daily Balance Of Power 0.71 
Seres Therapeutics Price Action Indicator 0.04 
Seres Therapeutics Accumulation Distribution 80,494 
Seres Therapeutics Price Rate Of Daily Change 1.06 

Seres Therapeutics January 30, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Seres Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Seres Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Seres Stock and then apply it to test your longer-term investment strategies against Seres.

Seres Stock Price History Data

The price series of Seres Therapeutics for the period between Fri, Nov 1, 2024 and Thu, Jan 30, 2025 has a statistical range of 0.43 with a coefficient of variation of 11.86. The daily prices for the period are spread out with arithmetic mean of 0.81. The median price for the last 90 days is 0.82.
OpenHighLowCloseVolume
01/30/2025 0.81  0.88  0.81  0.86  1,011,926 
01/29/2025 0.82  0.84  0.79  0.81  937,573 
01/28/2025 0.83  0.86  0.80  0.81  772,080 
01/27/2025 0.85  0.92  0.82  0.84  1,756,940 
01/24/2025 0.89  0.93  0.85  0.86  1,279,183 
01/23/2025 0.89  0.95  0.84  0.89  2,555,259 
01/22/2025 0.74  0.95  0.74  0.91  11,393,150 
01/21/2025 0.77  0.77  0.72  0.73  1,211,148 
01/17/2025 0.74  0.79  0.74  0.77  830,262 
01/16/2025 0.75  0.80  0.71  0.74  10,654,050 
01/15/2025 0.78  0.81  0.75  0.78  1,125,177 
01/14/2025 0.81  0.83  0.75  0.77  2,556,758 
01/13/2025 0.83  0.84  0.80  0.82  1,064,488 
01/10/2025 0.90  0.91  0.83  0.84  751,810 
01/08/2025 0.85  0.88  0.84  0.85  698,318 
01/07/2025 0.91  0.94  0.85  0.87  1,374,436 
01/06/2025 0.89  0.95  0.89  0.91  1,527,967 
01/03/2025 0.83  0.91  0.82  0.91  1,531,545 
01/02/2025 0.85  0.85  0.81  0.84  1,090,382 
12/31/2024 0.85  0.85  0.80  0.83  1,538,588 
12/30/2024 0.88  0.89  0.82  0.83  2,760,568 
12/27/2024 0.93  0.93  0.87  0.89  1,320,848 
12/26/2024 0.94  0.97  0.92  0.92  886,345 
12/24/2024 0.95  0.99  0.95  0.96  938,824 
12/23/2024 0.92  1.00  0.92  0.97  3,029,037 
12/20/2024 0.93  0.96  0.92  0.92  2,789,337 
12/19/2024 0.90  0.97  0.87  0.92  2,663,890 
12/18/2024 0.90  0.92  0.85  0.86  1,802,485 
12/17/2024 0.88  0.91  0.85  0.88  1,721,328 
12/16/2024 0.88  0.95  0.88  0.89  1,480,722 
12/13/2024 0.91  0.96  0.87  0.88  2,124,345 
12/12/2024 0.90  0.92  0.85  0.86  1,078,664 
12/11/2024 0.95  0.95  0.86  0.90  1,081,744 
12/10/2024 0.83  0.94  0.83  0.93  3,543,903 
12/09/2024 0.90  0.95  0.81  0.86  13,930,490 
12/06/2024 0.82  0.90  0.81  0.82  1,164,311 
12/05/2024 0.82  0.84  0.78  0.81  1,338,860 
12/04/2024 0.87  0.87  0.80  0.82  1,903,431 
12/03/2024 0.92  0.93  0.87  0.88  1,428,533 
12/02/2024 1.01  1.01  0.87  0.93  2,920,470 
11/29/2024 0.95  0.99  0.94  0.98  3,585,585 
11/27/2024 0.88  0.93  0.86  0.92  1,665,786 
11/26/2024 0.96  0.96  0.80  0.88  2,880,813 
11/25/2024 0.79  0.90  0.77  0.89  6,867,703 
11/22/2024 0.75  0.78  0.72  0.77  1,583,208 
11/21/2024 0.83  0.88  0.72  0.73  4,168,655 
11/20/2024 0.68  0.88  0.67  0.81  12,204,020 
11/19/2024 0.58  0.70  0.58  0.69  4,401,742 
11/18/2024 0.54  0.62  0.54  0.58  3,372,741 
11/15/2024 0.60  0.60  0.55  0.55  3,484,078 
11/14/2024 0.59  0.61  0.58  0.59  2,017,286 
11/13/2024 0.65  0.69  0.59  0.59  5,440,461 
11/12/2024 0.69  0.71  0.63  0.66  3,471,431 
11/11/2024 0.74  0.76  0.69  0.69  2,445,869 
11/08/2024 0.70  0.73  0.70  0.72  1,681,847 
11/07/2024 0.75  0.76  0.71  0.72  2,208,739 
11/06/2024 0.84  0.84  0.74  0.76  1,665,351 
11/05/2024 0.79  0.82  0.76  0.81  1,389,966 
11/04/2024 0.83  0.85  0.79  0.81  1,713,022 
11/01/2024 0.79  0.83  0.79  0.82  2,243,971 
10/31/2024 0.78  0.83  0.76  0.82  2,306,904 

About Seres Therapeutics Stock history

Seres Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Seres is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Seres Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Seres Therapeutics stock prices may prove useful in developing a viable investing in Seres Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding147.2 M154.6 M
Net Loss-225.1 M-213.9 M

Seres Therapeutics Quarterly Net Working Capital

8.1 Million

Seres Therapeutics Stock Technical Analysis

Seres Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Seres Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Seres Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Seres Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Seres Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Seres Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Seres to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Seres Stock analysis

When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum